EVMN Evommune, Inc. Common Stock
$21,53
Precio · May 20, 2026
Fundamentales a fecha de May 7, 2026
Rango 52S
$14–$33
40% of range
Calificación del Analista
BUY
16 analysts
Precio Objetivo
$52
+142% upside
P/E (TTM)
-1.5
ROE
-401.2%
Margen de Beneficio Neto
-529.8%
EVMN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$21.52
Capitalización Bursátil
$540M
P/E (TTM)
-1.5
BPA (TTM)
$-11.22
Ingresos (TTM)
$13M
Rendimiento div.
—
ROE
-401.2%
Deuda/Capital
—
Rango 52S
$14 – $33
EVMN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$13M
2024-12-31
→
2025-12-31
BPA
$-11.22
2024-12-31
→
2025-12-31
Flujo de caja libre
$-77M
2025-12-31
→
2025-12-31
Márgenes
-529.8%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
EVMN
Mediana de Pares
P/E (TTM)
-1.5
—
P/S (TTM) (P/V (TTM))
41.5
16.8
P/B (P/C)
2.6
2.7
Price / FCF (Precio / FCF)
-7.0
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
EVMN
Mediana de Pares
Operating Margin (Margen Operativo)
-623.6%
—
Net Profit Margin (Margen de Beneficio Neto)
-529.8%
-205.9%
ROA
-45.8%
-51.1%
ROE
-401.2%
-65.4%
ROIC
-39.4%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
EVMN
Mediana de Pares
Current Ratio (Ratio corriente)
8.6
7.7
Quick Ratio (Ratio Rápido)
8.3
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
EVMN
Mediana de Pares
Revenue YoY (Ingresos interanuales)
85.7%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
EVMN
Mediana de Pares
EVMN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
16 analistas
- Compra fuerte 6 37,5%
- Compra 9 56,2%
- Mantener 1 6,2%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
8 analistas · 2026-05-14
Mediana
$52.00
← Por Debajo de Todos los Objetivos
$21.52
Mín
$48.00
Máx
$55.00
Objetivo mediano
$52.00
+141,6%
Objetivo medio
$52.00
+141,6%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.21%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.64 | $-0.74 | 0.10% |
| 31 de diciembre de 2025 | $-1.43 | $-0.90 | -0.53% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $13M | $7M | |
| R&D Expense | $74M | $64M | |
| SG&A Expense | $20M | $13M | |
| Operating Expenses | $94M | $77M | |
| Operating Income | $-81M | $-70M | |
| Interest Income | $3M | $3M | |
| Other Non-op | $12M | $3M | |
| Pretax Income | $-69M | $-68M | |
| Income Tax | $0 | $0 | |
| Net Income | $-69M | $-67M | |
| EPS (Basic) | $-11.22 | $-45.29 | |
| EPS (Diluted) | $-11.22 | $-45.29 | |
| Shares (Basic) | 6,136,636 | 1,508,284 | |
| Shares (Diluted) | 6,136,636 | 1,508,284 | |
| EBITDA | $-80M | · |
Balance general 20
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $44M | $16M | |
| Short-term Investments | $105M | $56M | |
| Prepaid Expense | $4M | $2M | |
| Current Assets | $153M | $74M | |
| PP&E (Net) | $994.0K | $1M | |
| PP&E (Gross) | $3M | $2M | |
| Accum. Depreciation | $2M | $948.0K | |
| Other Non-current Assets | $101.0K | $61.0K | |
| Total Assets | $225M | $76M | |
| Accounts Payable | $8M | $8M | |
| Accrued Liabilities | $10M | $7M | |
| Current Liabilities | $18M | $28M | |
| Capital Leases | $1M | · | |
| Other Non-current Liabilities | · | $535.0K | |
| Total Liabilities | $19M | $29M | |
| Common Stock | $3.0K | $0 | |
| Retained Earnings | $-221M | $-152M | |
| Stockholders' Equity | $206M | $-144M | |
| Liabilities + Equity | $225M | $76M | |
| Shares Outstanding | 31,524,093 | 1,551,420 |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $600.0K | $500.0K | |
| Stock-based Comp | $6M | $2M | |
| Other Non-cash | $-14M | · | |
| Operating Cash Flow | $-76M | $-58M | |
| CapEx | $235.0K | $88.0K | |
| Investing Cash Flow | $-115M | $-4M | |
| Financing Cash Flow | $221M | $49M | |
| Net Change in Cash | $29M | $-13M | |
| Free Cash Flow | $-77M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -623.6% | · | |
| Net Margin | -529.8% | · | |
| Pretax Margin | -529.8% | · | |
| EBITDA Margin | -619.0% | · | |
| ROA | -45.8% | · | |
| ROE | -401.2% | · | |
| ROIC | -39.4% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 8.6 | · | |
| Quick Ratio | 8.3 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 85.7% | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $13M | · | |
| Net Income TTM | $-69M | · | |
| Market Cap | $540M | · | |
| P/E | -1.5 | · | |
| P/S | 41.5 | · | |
| P/B | 2.6 | · | |
| P / Tangible Book | 2.6 | · | |
| P / Cash Flow | -7.1 | · | |
| P / FCF | -7.0 | · | |
| Earnings Yield | -65.5% | · |
Estado de resultados 14
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $10M | $3M | $0 | |
| R&D Expense | $17M | $20M | $20M | $14M | $18M | |
| SG&A Expense | $7M | $9M | $4M | $4M | $4M | |
| Operating Expenses | $24M | $30M | $23M | $18M | $21M | |
| Operating Income | $-24M | $-30M | $-13M | $-15M | $-21M | |
| Interest Income | $2M | $1M | $862.0K | $613.0K | $727.0K | |
| Other Non-op | $2M | $1M | $853.0K | $475.0K | $728.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-22M | $-28M | $-12M | $-15M | $-21M | |
| EPS (Basic) | $-0.64 | $15.14 | $-8.07 | $-9.48 | $-14.60 | |
| EPS (Diluted) | $-0.64 | $15.14 | $-8.07 | $-9.48 | $-14.60 | |
| Shares (Basic) | 33,670,148 | 4,596,393 | 1,545,010 | 1,534,965 | 6,649 | |
| Shares (Diluted) | 33,670,148 | 4,596,393 | 1,545,010 | 1,534,965 | 6,649 | |
| EBITDA | $-24M | · | $-13M | · | · |
Balance general 20
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $44M | $27M | · | $16M | |
| Short-term Investments | $163M | $105M | $49M | · | $56M | |
| Prepaid Expense | $4M | $4M | $6M | · | $2M | |
| Current Assets | $216M | $153M | $82M | · | $74M | |
| PP&E (Net) | $2M | $994.0K | $970.0K | · | $1M | |
| PP&E (Gross) | $3M | $3M | · | · | $2M | |
| Accum. Depreciation | $1M | $2M | · | · | $948.0K | |
| Other Non-current Assets | $73.0K | $101.0K | $61.0K | · | $61.0K | |
| Total Assets | $322M | $225M | $85M | · | $76M | |
| Accounts Payable | $4M | $8M | $4M | · | $8M | |
| Accrued Liabilities | $5M | $10M | $6M | · | $7M | |
| Current Liabilities | $11M | $18M | $10M | · | $28M | |
| Capital Leases | $7M | $1M | $0 | · | · | |
| Other Non-current Liabilities | · | · | $261.0K | · | · | |
| Total Liabilities | $18M | $19M | $11M | · | $29M | |
| Common Stock | $4.0K | $3.0K | $0 | · | $0 | |
| Retained Earnings | $-243M | $-221M | $-193M | · | $-152M | |
| Stockholders' Equity | $305M | $206M | $-183M | · | $-144M | |
| Liabilities + Equity | $322M | $225M | $85M | · | $76M | |
| Shares Outstanding | 36,018,372 | 31,524,093 | 1,554,965 | · | 1,551,420 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| D&A | $100.0K | $326.0K | · | $200.0K | $360.0K | |
| Stock-based Comp | $3M | $4M | · | $544.0K | $494.0K | |
| Other Non-cash | $-9M | · | · | · | · | |
| Operating Cash Flow | $-28M | $-17M | · | $-24M | $-19M | |
| CapEx | $83.0K | $104.0K | · | $0 | $0 | |
| Investing Cash Flow | $-85M | $-123M | · | $14M | $-33M | |
| Financing Cash Flow | $117M | $157M | · | $-152.0K | $50M | |
| Net Change in Cash | $4M | $17M | · | $-11M | $-2M | |
| Free Cash Flow | $-28M | · | · | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Operating Margin | · | · | -133.3% | · | · | |
| Net Margin | · | · | -124.8% | · | · | |
| EBITDA Margin | · | · | -133.3% | · | · | |
| ROA | -13.4% | · | -29.5% | · | · | |
| ROE | -14.2% | · | 13.6% | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Current Ratio | 20.4 | · | 7.9 | · | · | |
| Quick Ratio | 19.9 | · | 7.3 | · | · |
Eficiencia 1
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.2 | · | · |
Valoración (TTM) 5
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Market Cap | $828M | · | · | · | · | |
| P/B | 2.7 | · | · | · | · | |
| P / Tangible Book | 2.7 | · | · | · | · | |
| P / Cash Flow | -30.1 | · | · | · | · | |
| P / FCF | -30.0 | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Ingresos | $13M | $7M |
| Margen Operativo % | -623.6% | — |
| Beneficio neto | $-69M | $-67M |
| EPS Diluido | $-11.22 | $-45.29 |
Balance general
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Ratio corriente | 8.6 | — |
| Ratio Rápido | 8.3 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Flujo de caja libre | $-77M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.